Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and BeyondMina Fazel(Université Claude Bernard Lyon 1), Mehdi Brahmi(Centre Léon Bérard)CancersMarch 7, 202310.3390/cancers15061643Cited by 20SaveCiteExport RISWatch citationsRelated PapersReasons for acceptance and refusal of early palliative care in patients included in early-phase clinical trials in a regional comprehensive cancer centre in France: protocol for a qualitative study|BMJ Open|2022|5Qualitative evaluation of motives for acceptance or refusal of early palliative care in patients included in early-phase clinical trials in a French comprehensive cancer center: the PALPHA study|Supportive Care in Cancer|2024|1